InvestSMART

Biome Australia Limited (ASX: BIO) - Announcements

Current share price for BIO : $0.415 0.005 (1.19%)+

ASX company news and announcements for Biome Australia Limited (BIO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Biome Australia Limited (BIO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Biome Australia Limited (BIO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Biome Australia Limited (BIO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$95 Patent Application Filed for Probiotic Strain BMB18 27 Apr 2026 9:02AM $0.325 $0.415 risen by 27.69%
$95 Change of Auditor 10 Apr 2026 5:11PM $0.345 $0.415 risen by 20.29%
$95 Notification of cessation of securities - BIO 1 Apr 2026 12:00PM $0.340 $0.415 risen by 22.06%
$95 Secondary Trading Notice 30 Mar 2026 5:53PM $0.315 $0.415 risen by 31.75%
$95 Application for quotation of securities - BIO 30 Mar 2026 5:46PM $0.315 $0.415 risen by 31.75%
$95 Secondary Trading Notice 20 Mar 2026 10:01AM $0.345 $0.415 risen by 20.29%
$95 Application for quotation of securities - BIO 20 Mar 2026 9:57AM $0.350 $0.415 risen by 18.57%
$95 Application for quotation of securities - BIO 20 Mar 2026 9:52AM $0.350 $0.415 risen by 18.57%
$95 Proposed issue of securities - BIO 19 Mar 2026 9:39AM $0.365 $0.415 risen by 13.70%
$95 Secondary Trading Notice 17 Mar 2026 6:02PM $0.375 $0.415 risen by 10.67%
$95 Application for quotation of securities - BIO 17 Mar 2026 5:57PM $0.375 $0.415 risen by 10.67%
$95 Change of Director's Interest Notice 13 Mar 2026 8:26AM $0.390 $0.415 risen by 6.41%
$95 Secondary Trading Notice 12 Mar 2026 5:10PM $0.390 $0.415 risen by 6.41%
$95 Application for quotation of securities - BIO 12 Mar 2026 5:06PM $0.390 $0.415 risen by 6.41%
$95 Expiry of Unlisted Options 10 Mar 2026 8:25AM $0.400 $0.415 risen by 3.75%
$95 H1 FY26 Results & Company Presentation 25 Feb 2026 8:26AM $0.410 $0.415 risen by 1.22%
$95 Biome First Half FY26 Results and Highlights 23 Feb 2026 8:44AM $0.405 $0.415 risen by 2.47%
$95 Appendix 4D & Half Yearly Report 23 Feb 2026 8:22AM $0.405 $0.415 risen by 2.47%
$95 Biome Half Year Results and Webinar 18 Feb 2026 8:14AM $0.420 $0.415 fallen by 1.19%
$95 Ethics Approval Granted for BMB18 Human Clinical Trial 3 Feb 2026 8:17AM $0.480 $0.415 fallen by 13.54%
$95 Biome secures distribution with Fullscript Canada 2 Feb 2026 8:20AM $0.450 $0.415 fallen by 7.78%
$95 Quarterly Activities & Cashflow Report 27 Jan 2026 8:46AM $0.440 $0.415 fallen by 5.68%
$95 Trading Update 5 Jan 2026 8:37AM $0.415 $0.415 fallen by 0%
$95 Biome Launches Human Clinical Trial on BMB18 15 Dec 2025 8:23AM $0.395 $0.415 risen by 5.06%
$95 Biome appoints incoming Chief Financial Officer 4 Dec 2025 8:37AM $0.395 $0.415 risen by 5.06%

26 - 50 of 321 results

Page 2 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.